Gilead Sciences, Inc.
Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
Last updated:
Abstract:
The present disclosure provides a composition comprising Compound 1, or a pharmaceutically acceptable salt thereof, cyclodextrin, and, optionally, pH adjusting agents.
Status:
Grant
Type:
Utility
Filling date:
1 May 2020
Issue date:
8 Mar 2022